Monoclonal antibodies and Fc fragments for treating solid tumors
Andrea M Eisenbeis, Stefan J GrauDepartment of Neurosurgery, University Hospital of Cologne, Cologne, GermanyAbstract: Advances in biotechnology, better understanding of pathophysiological processes, as well as the identification of an increasing number of molecular markers have facilitated the use...
        Enregistré dans:
      
    
                  | Auteurs principaux: | Eisenbeis AM, Grau SJ | 
|---|---|
| Format: | article | 
| Langue: | EN | 
| Publié: | Dove Medical Press    
    
      2012 | 
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/009d04495ef04c1abc9614686dbac149 | 
| Tags: | Ajouter un tag 
      Pas de tags, Soyez le premier à ajouter un tag!
   | 
Documents similaires
- 
                
        
          Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies        
                  
 par: Yuan Li, et autres
 Publié: (2010)
- 
                
        
          Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy        
                  
 par: Cruz E, et autres
 Publié: (2019)
- 
                
        
          Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors        
                  
 par: Tanaka T, et autres
 Publié: (2014)
- 
                
        
          Monoclonal Antibody Therapies for High Risk Neuroblastoma        
                  
 par: Furman WL
 Publié: (2021)
- 
                
        
          Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review        
                  
 par: Elsbernd PM, et autres
 Publié: (2021)